Preparation and clinical utility of leukocyte-reduced platelets.
Anderson
K C
KC
Harvard Medical School, Blood Component Laboratory, Dana-Farber Cancer Institute, Boston, Mass.
D002469:Cell Separation; D003586:Cytomegalovirus Infections / Q000517:prevention & control / Q000635:transmission; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D007958:Leukocyte Count; D017713:Platelet Transfusion / Q000009:adverse effects*; D016896:Treatment Outcome
D007518:Isoantibodies